PROMPT: PROmoting Diabetes Education and Management Through Peer Support and Team Referral

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05587348
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
90
1
4
27
3.3

Study Details

Study Description

Brief Summary

A 3-step project is proposed. Step 1 will test which BPA time point(s) maximize referral rates to DSMES services in the real world clinic setting (Aim 1). Step 2 will utilize that approach within a pilot study of six sites, comparing the effectiveness of peer support to improve attendance to DSMES services (Aim 2). Step 3 will engage stakeholders in designing a future large scale DSMES services trial to improve referral and attendance to DSMES classes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Best Practice Advisory
  • Behavioral: Peer Support
N/A

Detailed Description

Living with diabetes can be challenging, however Diabetes Self-Management Education and Support (DSMES) is well known to help persons with diabetes (PWDM) learn to cope with the uncertainties of life with diabetes. Unfortunately, DSMES is underutilized in the current health care setting. This is a multifactorial problem with the two largest issues being providers not referring patients and patients not attending the DSMES programs. These programs and the health care workers who support them have the potential to modify the disease course for many PWDM, including potentially modifying long term morbidity and mortality. A feasibility study to test the impact of best practice advisories (BPAs) delivered to the health care provider and the diabetes care and education (DCE) specialists via the electronic health record when a PWDM is identified as qualifying for DSMES. The investigators will determine if the BPAs influence the time to referral for DSMES as well as the factors that predict whether a patient is referred to DSMES. The investigators also propose to assess the impact of a peer support on motivating PWDM to attend DSMES and make healthier lifestyle choices. The investigators hypothesize that if PWDM are able to connect with a peer who is also living with diabetes, they may be more likely to attend DSMES. Finally, the investigators will assess qualitatively how the health care providers felt about the use of the BPA reminders, explore how the PWDM felt about the utility of the peer supporters, and the overall relevance of the diabetes education they received. From these lessons learned the investigators will work with the stakeholders to design a large, pragmatic randomized trial designed to increase the uptake of DSMES, a vital piece of the diabetes puzzle.

Aim 1. Evaluate the relative impact of BPAs on DSMES services among providers at 6 primary care clinics.The investigators will identify six primary care practices to deploy the suite of tools designed to increase patient referrals to DSMES classes. All six practices will be from within the state of North Carolina. The providers will be a mix of genders, and ages. Providers will be a convenience sample based upon the six practices that are identified to be a part of this study.

Aim 2. Conduct a 6-month pilot of DSMES among 90 PWDM randomized to one of two groups: usual care or peer support. The investigators will identify 90 PWD who are active adult patients with type 2 diabetes from one of the six practices identified in Aim 1.

Aim 3. Engage stakeholders in designing a future large scale DSMES services trial. The investigators will interview providers and patients from Aims 1 and 2 for the qualitative interviews planned in Aim 3.

Practices: Six primary care practices within the UNC Physicians Network (UNCPN) will be recruited. Based upon the strong relationship the investigators have built with the UNCPN over the past decade, the investigators will work with the UNCPN leadership team to identify practices most likely to be interested in participation. The investigators will ensure a diverse group of practices, including a mix of rural and urban locations. Upon identification of the potential practices, the seasoned practice facilitator will arrange lunch and learn sessions within the potential practices, where they will present the project and discuss the requirements of participating. Practices will have the opportunity to discuss participation amongst their team members, and the practice facilitator will follow up with them within a week to determine their interest in enrolling.

Patients: Patients who have been referred for DSMES classes will be consented and randomized to peer support or usual care. PWDM who are randomized to the peer support group will have standard DSMES classes and as well as support via a peer supporter. The no peer support group will receive standard DSMES class only. After a referral for DSMES class has been placed, the research team will contact them to discuss the pilot trial. Multiple recruitment approaches will be used including phone call, letter, email contact via Epic, the EPIC patient portal (MyChart) and informational flyers. Patients will be compensated for filling out surveys at baseline, 3 months, 6 months, and for optional focus group participation..

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
PROmoting Diabetes Education and Management Through Peer Support and Team Referral
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1. Best Practice Advisory

Four practices receive a suite of tools intended to increase the rate of referral to DSMES classes for patients with type 2 diabetes. In these four practices, the assigned DCE specialist will have access to a list of eligible patients who have upcoming appointments with their primary care providers. The DCE specialist will message the providers about the eligible patients via the EHR. They will also place a pended order for referral to DSMES class for the eligible patients. The health care provider will be able to either approve or deny the order for the referral Additionally, when an eligible patient presents for an appointment in one of the four intervention clinics, a best practice advisory (BPA) will fire within the EHR and encourage the provider to place a referral for DSMES classes.

Behavioral: Best Practice Advisory
Provider will get Best Practice Advisory or Message from DCE in intervention practices

Placebo Comparator: 2. Silent Best Practice Advisory

Two practices will not receive the suite of tools, but the lists and BPA will be created and sent to the research team.

Behavioral: Best Practice Advisory
Provider will get Best Practice Advisory or Message from DCE in intervention practices

Experimental: 3. Peer Support

45 patients in the 6 clinics who are referred to DSMES classes who enroll in the study will be assigned a peer supporter who will work with the participant and encourage attendance to the DSMES classes in addition to the usual support offered by the clinic.

Behavioral: Peer Support
Patients referred to DSMES classes will be randomized to get a peer supporter

Placebo Comparator: 4. Usual Care

45 patients in the 6 clinics who are referred to DSMES classes who enroll in the study will receive the usual support offered by the clinic.

Behavioral: Peer Support
Patients referred to DSMES classes will be randomized to get a peer supporter

Outcome Measures

Primary Outcome Measures

  1. Odds of referral for DSMES Placed through the Electronic Health Record (EHR) [30 days]

    EHR data from the Carolina Data Warehouse. Referral defined as within 30 days of patient seen in of office

  2. Odds of attending 1 DSMES class [3 months]

    EHR data -odds of attending 1 DSMES class within 3 months of referral

Secondary Outcome Measures

  1. Time from index patient visit to referral to DSMES [3 months]

    EHR data- number of days from patient visit to referral placed in EMR

  2. Time to get to DSMES class [3 months]

    EHR data- number of days from patient visit to attending DSMES class

  3. Number of PWD who attended at least 2 DSMES group classes [3 months]

    EHR data - patients who attended two DSMES classes

  4. Number of PWD who completed the entire DSMES class [3 months]

    EHR data - patients who attended the entire DSMES class series

  5. A1c - Baseline [Baseline]

    Pulled from EHR data

  6. Change in A1c from baseline to 3 months [Baseline, Month 3]

    Pulled from EHR data

  7. Change in A1c from baseline to 6 months [Baseline, Month 6]

    Pulled from EHR data

  8. Diabetes Distress - Baseline [Baseline]

    The Diabetes Distress Scale (DDS17) is a 17-item questionnaire assessing the severity of problems of living with diabetes. Participants indicate the degree to which each item impacts their life on a 6-point scale where 1 = not a problem and 6 = a very serious problem. The scores are summed and divided by 17 to generate an average score that can range from 1 to 6. Scores of 3 or more are considered high distress. The DDS17 has 4 sub-scores. A. Emotional burden, uses items 1,4, 7, 10, and 14 summed and divided by 5 to generate an average score. B. Physician distress, uses items 2, 5, 11, and15 summed and divided by 4 to generate an average score. C. Regimen distress, uses item 6, 8, 3, 12, and 16 summed and divided by 5 to generate an average score. D. Interpersonal distress, uses item 9,13, and 17 summed and divided by 3 to generate an average score. .

  9. Change in Diabetes Distress from baseline to 3 months [Baseline, Month 3]

    The Diabetes Distress Scale (DDS17) is a 17-item questionnaire assessing the severity of problems of living with diabetes. Participants indicate the degree to which each item impacts their life on a 6-point scale where 1 = not a problem and 6 = a very serious problem. The scores are summed and divided by 17 to generate an average score that can range from 1 to 6. Scores of 3 or more are considered high distress. The DDS17 has 4 sub-scores. A. Emotional burden, uses items 1,4, 7, 10, and 14 summed and divided by 5 to generate an average score. B. Physician distress, uses items 2, 5, 11, and15 summed and divided by 4 to generate an average score. C. Regimen distress, uses item 6, 8, 3, 12, and 16 summed and divided by 5 to generate an average score. D. Interpersonal distress, uses item 9,13, and 17 summed and divided by 3 to generate an average score.

  10. Change in Diabetes Distress from baseline to 6 months [Baseline, Month 6]

    The Diabetes Distress Scale (DDS17) is a 17-item questionnaire assessing the severity of problems of living with diabetes. Participants indicate the degree to which each item impacts their life on a 6-point scale where 1 = not a problem and 6 = a very serious problem. The scores are summed and divided by 17 to generate an average score that can range from 1 to 6. Scores of 3 or more are considered high distress. The DDS17 has 4 sub-scores. A. Emotional burden, uses items 1,4, 7, 10, and 14 summed and divided by 5 to generate an average score. B. Physician distress, uses items 2, 5, 11, and15 summed and divided by 4 to generate an average score. C. Regimen distress, uses item 6, 8, 3, 12, and 16 summed and divided by 5 to generate an average score. D. Interpersonal distress, uses item 9,13, and 17 summed and divided by 3 to generate an average score.

  11. Diabetes Self-Efficacy Baseline [Baseline]

    The Diabetes Self-Efficacy Survey Short Form (DES-SF) is an 8-item questionnaire assessing the ability of a person to self-manage their diabetes. Participants indicate the degree to which they agree with each of the statements on a 5 point scale where 1 = strongly disagree and 5 = strongly agree. The scores are summed and divided by 8 to generate an average score that can range from 1 to 5, with 5 indicating increased self-efficacy.

  12. Change in Diabetes Self-Efficacy from baseline to 3 months [Baseline, Month 3]

    The Diabetes Self-Efficacy Survey Short Form (DES-SF) is an 8-item questionnaire assessing the ability of a person to self-manage their diabetes. Participants indicate the degree to which they agree with each of the statements on a 5 point scale where 1 = strongly disagree and 5 = strongly agree. The scores are summed and divided by 8 to generate an average score that can range from 1 to 5 with 5 indicating increased self-efficacy

  13. Change in Diabetes Self-Efficacy from baseline to 6 months [Baseline, Month 6]

    The Diabetes Self-Efficacy Survey Short Form (DES-SF) is an 8-item questionnaire assessing the ability of a person to self-manage their diabetes. Participants indicate the degree to which they agree with each of the statements on a 5 point scale where 1 = strongly disagree and 5 = strongly agree. The scores are summed and divided by 8 to generate an average score that can range from 1 to 5 with 5 indicating increased self-efficacy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria Providers:
  • Primary Care Providers employed at the participating practices
Exclusion Criteria Providers:
  • Primary Care Providers that are not employed at the participating practices
Inclusion Criteria Patients:
  • Adult, English-speaking patients diagnosed with type 2 diabetes who are referred to DSMES classes from a provider at one of the study practices.
Exclusion Criteria Patients:
  • Any patients who are not referred to DSMES classes from the study practices

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Carolina at Chapel Hill Chapel Hill North Carolina United States 27599

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Principal Investigator: Laura Young, MD, PhD, UNC Chapel Hill
  • Principal Investigator: Katrina Donahue, MD, MPH, UNC Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT05587348
Other Study ID Numbers:
  • 22-0357
  • 1R34DK132571-01
First Posted:
Oct 20, 2022
Last Update Posted:
Oct 20, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of North Carolina, Chapel Hill
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 20, 2022